Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iduronate 2-sulfatase pseudogene 1 (IDSP1, also called IDS2) is a non-coding pseudogene found on the X chromosome near the functional *IDS* gene. Unlike *IDS*, which encodes the lysosomal enzyme iduronate 2-sulfatase (I2S) responsible for glycosaminoglycan catabolism, IDSP1/IDS2 lacks protein-coding function. Complex recombination events between *IDS* and its pseudogene (IDSP1/IDS2) can cause pathogenic deletions or rearrangements of *IDS*, leading to Hunter syndrome (Mucopolysaccharidosis type II). The pseudogene itself is not a therapeutic target, biomarker, or functional protein, but its presence has important implications for the genetics and diagnosis of MPS II[3][6][7].
None (not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iduronate 2-sulfatase pseudogene 1 (IDSP1).